This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints, Permissions and Rights Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Norata, G. D. Articles by Catapano, A. L. Search for Related Content PubMed PubMed Citation Articles by Norata, G. D. Articles by Catapano, A. L. Related Collections Cardiovascular Endocrinology Male Endocrinology

Dihydrotestosterone Decreases Tumor Necrosis Factor- and Lipopolysaccharide-Induced Inflammatory Response in Human Endothelial Cells

Department of Pharmacological Sciences (G.D.N., G.T., P.M.S., A.L.C.) and Institute of Endocrinology (A.P.), Centre of Excellence on Neurodegenerative Diseases, University of Milan, 20133 Milan, Italy; and Center for the Prevention and Therapy of Global Cardiovascular Risk (G.D.N., A.L.C.), Italian Society for the Study of Atherosclerosis, Bassini Hospital, 20092 Cinisello Balsamo, Italy

Address all correspondence and requests for reprints to: Giuseppe Danilo Norata, Ph.D., Department of Pharmacological Sciences, University of Milan, Italy, Via Balzaretti 9, 20133, Milan, Italy. E-mail: Danilo.Norata{at}unimi.it.

Context: An increasing body of evidence suggests that testosterone may exert beneficial effects on the development of atherosclerosis. It was suggested that testosterone may act after conversion into estradiol and activation of the estrogen receptors; however, a direct role of androgens on the vascular wall has been proposed.

Objective: We investigated the effects of dihydrotestosterone on the proinflammatory response observed in human endothelial cells.

Design: Human endothelial cells isolated from umbilical cords were incubated with lipopolysaccharide or TNF in the presence or absence of dihydrotestosterone (DHT). mRNA and cellular proteins were processed for gene expression studies, and transient transfection experiments were performed to investigate molecular mechanisms involved in the effects observed.

Setting: These studies took place at the Department of Pharmacological Sciences, University of Milan, Milan, Italy.

Results: Lipopolysaccharide and TNF induced VCAM-1 and ICAM-1 mRNA and protein expression, as detected by real-time quantitative PCR, fluorescence-activated cell sorting, and confocal microscopy, but this effect was inhibited when cells were incubated with DHT. In addition, DHT inhibited mRNA expression of IL-6, MCP-1, CD40, TLR4, PAI-1, and Cox-2 and the release of cytokines and chemokines such as GRO, granulocyte-macrophage colony-stimulating factor, and TNF. The DHT effect was counteracted by bicalutamide, an antagonist of the androgen receptor. Furthermore, when cells were cotransfected with a Cox-2 promoter or a 3X-NF-B luciferase reporter vector and a plasmid expressing the human androgen receptor, DHT treatment inhibited the increase of the luciferase activity observed with TNF.

Conclusion: DHT could positively regulate endothelial function through the control of the inflammatory response mediated by nuclear factor-B in endothelial cells.

This article has been cited by other articles:

				M. Lasa, B. Gil-Araujo, M. Palafox, and A. Aranda Thyroid Hormone Antagonizes Tumor Necrosis Factor-{alpha} Signaling in Pituitary Cells through the Induction of Dual Specificity Phosphatase 1 Mol. Endocrinol., February 1, 2010; 24(2): 412 - 422. [Abstract] [Full Text] [PDF]

				D. Wang, R. B. Montgomery, L. J. Schmidt, E. A. Mostaghel, H. Huang, P. S. Nelson, and D. J. Tindall Reduced Tumor Necrosis Factor Receptor-Associated Death Domain Expression Is Associated with Prostate Cancer Progression Cancer Res., December 15, 2009; 69(24): 9448 - 9456. [Abstract] [Full Text] [PDF]

				H. Liu, A. E Dear, L. B Knudsen, and R. W Simpson A long-acting glucagon-like peptide-1 analogue attenuates induction of plasminogen activator inhibitor type-1 and vascular adhesion molecules J. Endocrinol., April 1, 2009; 201(1): 59 - 66. [Abstract] [Full Text] [PDF]

				A. M. Traish, F. Saad, and A. Guay The Dark Side of Testosterone Deficiency: II. Type 2 Diabetes and Insulin Resistance J Androl, January 1, 2009; 30(1): 23 - 32. [Abstract] [Full Text] [PDF]

				W. Kim and J. M. Egan The Role of Incretins in Glucose Homeostasis and Diabetes Treatment Pharmacol. Rev., December 1, 2008; 60(4): 470 - 512. [Abstract] [Full Text] [PDF]

				A. Pirillo, P. Uboldi, C. Bolego, H. Kuhn, and A. L. Catapano The 15-Lipoxygenase-Modified High Density Lipoproteins 3 Fail to Inhibit the TNF-{alpha}-Induced Inflammatory Response in Human Endothelial Cells J. Immunol., August 15, 2008; 181(4): 2821 - 2830. [Abstract] [Full Text] [PDF]

				J. A. Rettew, Y. M. Huet-Hudson, and I. Marriott Testosterone Reduces Macrophage Expression in the Mouse of Toll-Like Receptor 4, a Trigger for Inflammation and Innate Immunity Biol Reprod, March 1, 2008; 78(3): 432 - 437. [Abstract] [Full Text] [PDF]

				H. Liu, Y. Hu, R. W Simpson, and A. E Dear Glucagon-like peptide-1 attenuates tumour necrosis factor-{alpha}-mediated induction of plasmogen activator inhibitor-1 expression J. Endocrinol., January 1, 2008; 196(1): 57 - 65. [Abstract] [Full Text] [PDF]

				P. P. Liu and M. Fukuoka Sex Hormones as Novel Risk Biomarkers for Atherosclerosis in Peripheral Vascular Disease J. Am. Coll. Cardiol., September 11, 2007; 50(11): 1077 - 1079. [Full Text] [PDF]

				A. V. D'Amico, J. W. Denham, J. Crook, M.-H. Chen, S. Z. Goldhaber, D. S. Lamb, D. Joseph, K.-H. Tai, S. Malone, C. Ludgate, et al. Influence of Androgen Suppression Therapy for Prostate Cancer on the Frequency and Timing of Fatal Myocardial Infarctions J. Clin. Oncol., June 10, 2007; 25(17): 2420 - 2425. [Abstract] [Full Text] [PDF]

				E. Debing, E. Peeters, W. Duquet, K. Poppe, B. Velkeniers, and P. Van den Brande Endogenous sex hormone levels in postmenopausal women undergoing carotid artery endarterectomy Eur. J. Endocrinol., June 1, 2007; 156(6): 687 - 693. [Abstract] [Full Text] [PDF]